Advisory Board April 30, 2024

As demand for Adderall and other stimulants continues to rise, some federal officials say the situation resembles the start of the opioid epidemic and that “we’re at the precipice of our next drug crisis in the United States.”

Case study: How Shatterproof established national substance use care standards

A surge in Adderall use

Adderall and other stimulants are used to treat ADHD and narcolepsy. Because stimulants can be addictive and abused, they are considered controlled substances, and the federal government limits how they can be produced, prescribed, and distributed.

During the COVID-19 pandemic, telehealth became more popular and led to a significant increase in Adderall prescriptions. In 2023, there were 45 million prescriptions for Adderall, compared to 35.5 million in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Bipartisan scrutiny of health care mergers
Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
AZ plots $1.5B antibody-drug conjugate plant in Asia
STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality

Share This Article